These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34973495)

  • 21. Bidirectional signaling through ephrinA2-EphA2 enhances osteoclastogenesis and suppresses osteoblastogenesis.
    Irie N; Takada Y; Watanabe Y; Matsuzaki Y; Naruse C; Asano M; Iwakura Y; Suda T; Matsuo K
    J Biol Chem; 2009 May; 284(21):14637-44. PubMed ID: 19299512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neural regulation of bone remodeling: Identifying novel neural molecules and pathways between brain and bone.
    Huang S; Li Z; Liu Y; Gao D; Zhang X; Hao J; Yang F
    J Cell Physiol; 2019 May; 234(5):5466-5477. PubMed ID: 29377116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repulsion or adhesion: receptors make the call.
    Halloran MC; Wolman MA
    Curr Opin Cell Biol; 2006 Oct; 18(5):533-40. PubMed ID: 16930978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Boning up on ephrin signaling.
    Mundy GR; Elefteriou F
    Cell; 2006 Aug; 126(3):441-3. PubMed ID: 16901775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in the regulation of osteoclasts and osteoclast functions.
    Boyce BF
    J Dent Res; 2013 Oct; 92(10):860-7. PubMed ID: 23906603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta-Arrestin2 regulates RANKL and ephrins gene expression in response to bone remodeling in mice.
    Pierroz DD; Rufo A; Bianchi EN; Glatt V; Capulli M; Rucci N; Cavat F; Rizzoli R; Teti A; Bouxsein ML; Ferrari SL
    J Bone Miner Res; 2009 May; 24(5):775-84. PubMed ID: 19113915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin like growth factor-I: a critical mediator of the skeletal response to parathyroid hormone.
    Bikle DD; Wang Y
    Curr Mol Pharmacol; 2012 Jun; 5(2):135-42. PubMed ID: 21787292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombospondins in bone remodeling and metastatic bone disease.
    Carminati L; Taraboletti G
    Am J Physiol Cell Physiol; 2020 Dec; 319(6):C980-C990. PubMed ID: 32936697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Rho-GEF Kalirin regulates bone mass and the function of osteoblasts and osteoclasts.
    Huang S; Eleniste PP; Wayakanon K; Mandela P; Eipper BA; Mains RE; Allen MR; Bruzzaniti A
    Bone; 2014 Mar; 60():235-45. PubMed ID: 24380811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A class III semaphorin (Sema3e) inhibits mouse osteoblast migration and decreases osteoclast formation in vitro.
    Hughes A; Kleine-Albers J; Helfrich MH; Ralston SH; Rogers MJ
    Calcif Tissue Int; 2012 Feb; 90(2):151-62. PubMed ID: 22227882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone remodeling in the context of cellular and systemic regulation: the role of osteocytes and the nervous system.
    Niedźwiedzki T; Filipowska J
    J Mol Endocrinol; 2015 Oct; 55(2):R23-36. PubMed ID: 26307562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Semaphorin 3B is a 1,25-Dihydroxyvitamin D3-induced gene in osteoblasts that promotes osteoclastogenesis and induces osteopenia in mice.
    Sutton AL; Zhang X; Dowd DR; Kharode YP; Komm BS; Macdonald PN
    Mol Endocrinol; 2008 Jun; 22(6):1370-81. PubMed ID: 18356290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Friend or Foe? Essential Roles of Osteoclast in Maintaining Skeletal Health.
    Wang H; Yang G; Xiao Y; Luo G; Li G; Li Z
    Biomed Res Int; 2020; 2020():4791786. PubMed ID: 32190665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The regulatory mechanisms of bone metabolism by semaphorin].
    Hayashi M; Nakashima T; Takayanagi H
    Clin Calcium; 2012 Nov; 22(11):1693-9. PubMed ID: 23103813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Semaphorin and osteoporosis.].
    Hayashi M; Nakashima T
    Clin Calcium; 2016; 26(10):1419-1427. PubMed ID: 27666689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Local communication on and within bone controls bone remodeling.
    Henriksen K; Neutzsky-Wulff AV; Bonewald LF; Karsdal MA
    Bone; 2009 Jun; 44(6):1026-33. PubMed ID: 19345750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Semaphorin 4D Promotes Skeletal Metastasis in Breast Cancer.
    Yang YH; Buhamrah A; Schneider A; Lin YL; Zhou H; Bugshan A; Basile JR
    PLoS One; 2016; 11(2):e0150151. PubMed ID: 26910109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maintenance of Bone Homeostasis by DLL1-Mediated Notch Signaling.
    Muguruma Y; Hozumi K; Warita H; Yahata T; Uno T; Ito M; Ando K
    J Cell Physiol; 2017 Sep; 232(9):2569-2580. PubMed ID: 27735989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lysophosphatidic acid: a potential mediator of osteoblast-osteoclast signaling in bone.
    Sims SM; Panupinthu N; Lapierre DM; Pereverzev A; Dixon SJ
    Biochim Biophys Acta; 2013 Jan; 1831(1):109-16. PubMed ID: 22892679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteoblast-derived microvesicles: A novel mechanism for communication between osteoblasts and osteoclasts.
    Deng L; Wang Y; Peng Y; Wu Y; Ding Y; Jiang Y; Shen Z; Fu Q
    Bone; 2015 Oct; 79():37-42. PubMed ID: 26013558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.